National Endocrine and Metabolic Diseases Information Service What is a prolactinoma? A prolactinoma is a benign—noncancerous—
tumor of the pituitary gland that produces a
hormone called prolactin. Prolactinomas are
U.S. Department of Health and
the most common type of pituitary tumor.
Human Services
hyperprolactinemia—too much prolactin in
NATIONAL
the blood—or by pressure of the tumor on
INSTITUTES OF HEALTH
Prolactin stimulates the breast to produce
milk during pregnancy. After giving birth,
a mother’s prolactin levels fall unless she
breastfeeds her infant. Each time the baby
nurses, prolactin levels rise to maintain milk
What is the pituitary gland? The pituitary gland, sometimes called the
master gland, plays a critical role in regulat
and reproduction. It produces prolactin and
The pituitary gland sits in the sella turcica.
The pituitary gland sits in the middle of the
head in a bony box called the sella turcica.
The optic nerves sit directly above the pitu
itary gland. Enlargement of the gland can
cause symptoms such as headaches or visual
What causes prolactinoma?
impair production of one or more pituitary
hormones, causing reduced pituitary func
largely unknown. Most pituitary tumors are
sporadic, meaning they are not genetically
How common is What else causes prolactin prolactinoma?
Although small benign pituitary tumors are
fairly common in the general population,
In some people, high blood levels of pro
lactin can be traced to causes other than
Prescription drugs. Prolactin secretion in
the pituitary is normally suppressed by the
What are the symptoms of
brain chemical dopamine. Drugs that block
prolactinoma?
the effects of dopamine at the pituitary or
deplete dopamine stores in the brain may
In women, high levels of prolactin in the
cause the pituitary to secrete prolactin.
blood often cause infertility and changes in
menstruation. In some women, periods may
medications such as trifluoperazine (Stela
stop. In others, periods may become irregu
zine) and haloperidol (Haldol); the newer
antipsychotic drugs risperidone (Risperdal)
who are not pregnant or nursing may begin
(Reglan), used to treat gastroesophageal
experience a loss of libido—interest in sex.
Intercourse may become painful because of
cancer drugs; and less often, verapamil,
alpha–methyldopa (Aldochlor, Aldoril),
and reserpine (Serpalan, Serpasil), used to
lactinoma is erectile dysfunction. Because
control high blood pressure. Some antide
pressants may cause hyperprolactinemia, but
changes in menstruation to signal a problem,
many men delay going to the doctor until
Other pituitary tumors. Other tumors
they have headaches or eye problems caused
arising in or near the pituitary may block
by the enlarged pituitary pressing against
nearby optic nerves. They may not recognize
the prolactin-secreting cells. Such tumors
a gradual loss of sexual function or libido.
include those that cause acromegaly, a condi
Only after treatment do some men realize
they had a problem with sexual function.
and Cushing’s syndrome, caused by too much
cortisol. Other pituitary tumors that do not
Hypothyroidism. Increased prolactin levels How is prolactinoma
are often seen in people with hypothyroid
treated?
ism, a condition in which the thyroid does
The goals of treatment are to return prolac
Doctors routinely test people with hyperpro
tin secretion to normal, reduce tumor size,
correct any visual abnormalities, and restore
normal pituitary function. In the case of
Chest involvement. Nipple stimulation also
large tumors, only partial achievement of
can cause a modest increase in the amount of
prolactin in the blood. Similarly, chest wall
injury or shingles involving the chest wall
Medical Treatment
normally inhibits prolactin secretion, doc
How is prolactinoma
tors may treat prolactinoma with the dop
diagnosed?
amine agonists bromocriptine (Parlodel) or
cabergoline (Dostinex). Agonists are drugs
A doctor will test for prolactin blood levels
that act like a naturally occurring substance.
in women with unexplained milk secretion,
called galactorrhea, or with irregular menses
prolactin levels to normal in approximately
or infertility and in men with impaired sexual
function and, in rare cases, milk secretion.
If prolactin levels are high, a doctor will test
Administration for the treatment of hyper
thyroid function and ask first about other
prolactinemia. Bromocriptine is the only
conditions and medications known to raise
dopamine agonist approved for the treat
prolactin secretion. The doctor may also
ment of infertility. This drug has been in
request magnetic resonance imaging (MRI),
use longer than cabergoline and has a well-
which is the most sensitive test for detecting
pituitary tumors and determining their size.
MRI scans may be repeated periodically to
assess tumor progression and the effects of
effects of bromocriptine. To avoid these
side effects, bromocriptine treatment must
scan also gives an image of the pituitary but
be started slowly. A typical starting dose is
one-quarter to one-half of a 2.5 milligram
(mg) tablet taken at bedtime with a snack.
The dose is gradually increased every 3 to
surrounding tissues and perform tests to
7 days as needed and taken in divided doses
assess whether production of other pituitary
with meals or at bedtime with a snack. Most
hormones is normal. Depending on the size
people are successfully treated with 7.5 mg
of the tumor, the doctor may request an eye
a day or less, although some people need
mocriptine is short acting, it should be taken
those used for prolactinomas, heart valve
endocrinologist—a doctor specializing in
disorders of the hormone-producing glands.
people taking low doses of cabergoline to
Prolactin levels rise again in most people
treat hyperprolactinemia. Before starting
these medications, the doctor will order an
however, prolactin levels remain normal, so
the doctor may suggest reducing or discon
sonogram of the heart that checks the heart
tinuing treatment every 2 years on a trial
Because limited information exists about
the risks of long-term, low-dose cabergoline
more effective than bromocriptine in nor
use, doctors generally prescribe the lowest
malizing prolactin levels and shrinking tumor
effective dose and periodically reassess the
size. Cabergoline also has less frequent and
need for continuing therapy. People taking
less severe side effects. Cabergoline is more
cabergoline who develop symptoms of short
ness of breath or swelling of the feet should
newer on the market, its long-term safety
promptly notify their physician because these
record is less well defined. As with bro
mocriptine therapy, nausea and dizziness are
possible side effects but may be avoided if
treatment is started slowly. The usual start
Surgery to remove all or part of the tumor
ing dose is .25 mg twice a week. The dose
should only be considered if medical therapy
may be increased every 4 weeks as needed,
cannot be tolerated or if it fails to reduce
up to 1 mg two times a week. Cabergoline
prolactin levels, restore normal reproduction
should not be stopped without consulting a
and pituitary function, and reduce tumor
size. If medical therapy is only partially
Recent studies suggest prolactin levels are
successful, it should be continued, possibly
more likely to remain normal after discon
tinuing long-term cabergoline therapy than
Most often, the tumor is removed through
the nasal cavity. Rarely, if the tumor is large
research is needed to confirm these findings.
or has spread to nearby brain tissue, the
surgeon will access the tumor through an
mocriptine to treat Parkinson’s disease
The results of surgery depend a great deal
How does prolactinoma
on tumor size and prolactin levels as well as
affect pregnancy?
the skill and experience of the neurosurgeon.
The higher the prolactin level before surgery,
If a woman has a small prolactinoma, she
the lower the chance of normalizing serum
prolactin. Serum is the portion of the blood
pregnancy after effective medical therapy. If
used in measuring prolactin levels. In the
she had a successful pregnancy before, the
best medical centers, surgery corrects pro
chance of her having more successful preg
lactin levels in about 80 percent of patients
with small tumors and a serum prolactin less
A woman with prolactinoma should discuss
than 200 nanograms per milliliter (ng/ml).
her plans to conceive with her physician
A surgical cure for large tumors is lower, at
so she can be carefully evaluated prior to
30 to 40 percent. Even in patients with large
tumors that cannot be completely removed,
include an MRI scan to assess the size of the
drug therapy may be able to return serum
tumor and an eye examination with measure
prolactin to the normal range—20 ng/ml or
ment of visual fields. As soon as a woman is
less—after surgery. Depending on the size
pregnant, her doctor will usually advise her
of the tumor and how much of it is removed,
to stop taking bromocriptine or cabergoline.
studies show that 20 to 50 percent will recur,
Although these drugs are safe for the fetus in
early pregnancy, their safety throughout an
Because the results of surgery are so depen
entire pregnancy has not been established.
dent on the skill and knowledge of the neu
Many doctors prefer to use bromocriptine
rosurgeon, a patient should ask the surgeon
about the number of operations he or she
because it has a longer record of safety in
has performed to remove pituitary tumors
and for success and complication rates in
The pituitary enlarges and prolactin produc
comparison to major medical centers. The
tion increases during pregnancy in women
best results come from surgeons who have
prolactin-secreting tumors may experience
such operations. To find a surgeon, con
further pituitary enlargement and must be
tact The Pituitary Society (see For More
closely monitored during pregnancy. Less
than 3 percent of pregnant women with small
Radiation
growth such as headaches or vision problems.
Rarely, radiation therapy is used if medical
In women with large prolactinomas, the risk
therapy and surgery fail to reduce prolactin
of symptomatic tumor growth is greater, and
levels. Depending on the size and location of
the tumor, radiation is delivered in low doses
over the course of 5 to 6 weeks or in a single
high dose. Radiation therapy is effective
Most endocrinologists see patients every
Is osteoporosis a risk in women with high prolactin
woman should consult her endocrinologist
promptly if she develops symptoms of tumor
changes, nausea, vomiting, excessive thirst or
estrogen are at increased risk for osteoporo
urination, or extreme lethargy. Bromocrip
sis. Hyperprolactinemia can reduce estrogen
tine or, less often, cabergoline treatment may
production. Although estrogen production
be reinitiated and additional treatment may
may be restored after treatment for hyper
be required if the woman develops symptoms
How do oral contraceptives and hormone replacement
calcium intake through diet or supplements
therapy affect prolactinoma? hyperprolactinemia may want to have peri Oral contraceptives are not thought to con
odic bone density measurements and discuss
tribute to the development of prolactinomas,
estrogen replacement therapy or other bone-
although some studies have found increased
strengthening medications with their doctor.
medications. Because oral contraceptives
may produce regular menstrual bleeding in
women who would otherwise have irregular
menses due to hyperprolactinemia, prolac
menses are absent or irregular. Women with
prolactinoma treated with bromocriptine or
cabergoline may safely take oral contracep
treated with medical therapy or surgery for
prolactinoma may be candidates for estrogen
Hope through Research Points to Remember
Researchers are working to identify a gene
or genes that may contribute to the develop
ment of pituitary tumors, including sporadic
tumors. They are also investigating certain
side effects of long-term treatment for pro
Participants in clinical trials can play a more
active role in their own health care, gain
access to new research treatments before
they are widely available, and help others by
contributing to medical research. For infor
For More Information American Association of Clinical Endocrinologists
• The first line of treatment is usually
The Endocrine Society
Phone: 1–888–363–6274 or 301–941–0200
The Pituitary Society Acknowledgments National Endocrine and Metabolic Diseases Information Service
tists and outside experts. This publication
was reviewed by Michael O. Thorner, M.B.,
D.Sc., University of Virginia Health System,
You may also find additional information about this
topic by visiting MedlinePlus at www.medlineplus.gov.
The National Endocrine and Metabolic Dis-
This publication may contain information about
eases Information Service is an information
medications. When prepared, this publication
included the most current information available.
dissemination service of the National Insti-
For updates or for questions about any medications,
tute of Diabetes and Digestive and Kidney
contact the U.S. Food and Drug Administration
toll-free at 1–888–INFO–FDA (1–888–463–6332)
or visit www.fda.gov. Consult your doctor for more
the National Institutes of Health, which is
part of the U.S. Department of Health and
The U.S. Government does not endorse or favor any
medical research. As a public service, the
specific commercial product or company. Trade,
proprietary, or company names appearing in this
NIDDK has established information services
document are used only because they are considered
necessary in the context of the information provided.
about health and disease among patients,
If a product is not mentioned, the omission does not
mean or imply that the product is unsatisfactory.
health professionals, and the public.
This publication is not copyrighted. The NIDDK
encourages users of this publication to duplicate and
distribute as many copies as desired. This fact sheet is also available at
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health
Health Care Family Planning Sterilization Abortion The Minor and Health Care Children's Health Insurance Mental Health Access to Medical Records and Related Rights Advance Directives Long-Term Care Decision Making Emergency Medical Care Medicare Medicaid Contributing Authors: Roberta Green Dina Mohler Susan Saxe Dr. Alvin "Woody" Mos
Il Tribunale Amministrativo Regionale per il Veneto, terza Sezione, sul ricorso n. 1832/04, proposto da Acab s.r.l., Autotrasporti Serragiotto s.n.c., Baggiotech s.r.l., Eureka s.r.l., G.B. Toniolo s.n.c, Project s.r.l., Road s.r.l., Sirmax s.p.a., in persona dei rispettivi rappresentanti pro tempore , rappresentati e difesi dall’avv. Pierfrancesco Zen, con elezione di domicilio presso l